Latest Insider Transactions at Biodelivery Sciences International Inc (BDSI)
This section provides a real-time view of insider transactions for Biodelivery Sciences International Inc (BDSI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BIODELIVERY SCIENCES INTERNATIONAL INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BIODELIVERY SCIENCES INTERNATIONAL INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 12
2021
|
Scott M. Plesha Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,834
+6.95%
|
-
|
|
Mar 09
2021
|
Jeffrey Allen Bailey Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,333
+11.54%
|
-
|
|
Feb 08
2021
|
James Vollins Officer |
SELL
Open market or private sale
|
Direct |
3,833
-100.0%
|
$15,332
$4.16 P/Share
|
|
Feb 04
2021
|
James Vollins Officer |
SELL
Open market or private sale
|
Direct |
8,303
-68.42%
|
$24,909
$3.97 P/Share
|
|
Feb 01
2021
|
Thomas B Smith Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,667
+27.76%
|
-
|
|
Feb 01
2021
|
James Vollins Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,833
+24.0%
|
-
|
|
Feb 01
2021
|
Scott M. Plesha Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,333
+4.91%
|
-
|
|
Feb 01
2021
|
Mary Theresa Coelho Officer |
SELL
Open market or private sale
|
Direct |
3,460
-10.15%
|
$10,380
$3.87 P/Share
|
|
Jan 29
2021
|
Thomas B Smith Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,548
+38.05%
|
-
|
|
Jan 29
2021
|
James Vollins Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,303
+50.0%
|
-
|
|
Jan 29
2021
|
Scott M. Plesha Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,870
+4.25%
|
-
|
|
Jan 29
2021
|
Mary Theresa Coelho Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,190
+23.02%
|
-
|
|
Jan 19
2021
|
Mary Theresa Coelho Officer |
SELL
Open market or private sale
|
Direct |
6,462
-21.29%
|
$25,848
$4.32 P/Share
|
|
Jan 15
2021
|
Mary Theresa Coelho Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,333
+37.66%
|
-
|
|
Dec 16
2020
|
James Vollins Officer |
SELL
Open market or private sale
|
Direct |
9,505
-100.0%
|
$38,020
$4.48 P/Share
|
|
Dec 16
2020
|
James Vollins Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,505
+50.0%
|
$28,515
$3.46 P/Share
|
|
Dec 15
2020
|
Jeffrey Allen Bailey Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
10,000
-21.95%
|
$40,000
$4.35 P/Share
|
|
Dec 14
2020
|
James Vollins Officer |
SELL
Open market or private sale
|
Direct |
20,320
-100.0%
|
$81,280
$4.46 P/Share
|
|
Dec 14
2020
|
James Vollins Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,320
+50.0%
|
$60,960
$3.46 P/Share
|
|
Nov 23
2020
|
Vanila Singh Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,333
+30.62%
|
-
|
|
Nov 04
2020
|
Jeffrey Allen Bailey Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+46.75%
|
-
|